Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer

British Journal of Cancer

Volumn 88, Issue 9, 2003, Pages 1406-1410

  Langelotz, C ^a   Schmid, P ^a   Jakob, C ^a   Heider, U ^a   Wernecke, K D ^a   Possinger, K ^a   Sezer, O ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

HMGI C; Independent prognostic factor; Metastatic breast cancer

Indexed keywords

ESTROGEN RECEPTOR; HIGH MOBILITY GROUP PROTEIN; HIGH MOBILITY GROUP PROTEIN C; MESSENGER RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD; BREAST CANCER; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MENOPAUSE; MIDDLE AGED; PROGNOSIS; RNA, MESSENGER; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0038823529     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600935     Document Type: Article

References (29)

1. Abe N, Watanabe T, Sugiyama M, Uchimura H, Chiapetta G, Fusco A, Atomi Y (1999) Determination of high mobility group I(Y) expression levels in colorectal neoplasias: a potential diagnostic marker. Cancer Res 59: 1169-1174
2. Berlingieri MT, Manfioletti G, Santoro M, Bandiera A, Visconti R, Giancotti V, Fusco A (1995) Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol 15: 1545-1553
3. Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, Hoon DS (1998) Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16: 2632-2640
4. Bustin M, Reeves R (1996) High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucl Acid Res Mol Biol 54: 35-100
5. Chau K, Arlotta P, Patel UA, Crane-Robinson C, Manfioletti G, Ono SJ (1999) A novel downstream positive regulatory element mediating transcription of the human high-mobility-group-protein (HMGI-C) gene. FEBS Lett 457: 429-436
6. Chiappetta G, Bandiera A, Berlingieri MT, Visconti R, Manfioletti G, Battista S, Martinez-Tello FJ, Santoro M, Giancotti V, Fusco A (1995) The expression of the high mobility group HMGI(Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene 10: 1307-1314
7. Giannini G, Di Marcotullio L, Ristori E, Zani M, Crescenzi M, Scarpa S, Piaggio G, Vacca A, Peverali FA, Diana F, Screpanti I, Frati L, Gulino A (1999) HMGI(Y) and HMGI-. Cancer Res 59: 2484-2492
8. Goodwin G (1998) Molecules in focus -the high mobility group protein HMGI-C. Int J Biochem Cell Biol 30: 761-766
9. Honkoop AH, van Diest PJ, de Jong JS, Linn SC, Giaccone G, Hoekman K, Wagstaff J, Pinedo HM (1998) Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer. Br J Cancer 77: 621-626
10. Kazmierczak B, Bullerdiek J, Pham KH, Bartnitzke S, Wiesner H (1998) Intron 3 of HMGI-C is the most frequent target of chromosomal aberrations in human tumors and has been conserved basically for at least 30 million years. Cancer Genet Cytogenet 103: 175-177
11. Kazmierczak B, Rosigkeit J, Wanschura S, Meyer-Bolte K, Van de Ven WJ, Kayser K, Krieghoff B, Kastendiek H, Bartnitzke S, Bullerdiek J (1996) HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors. Oncogene 12: 515-521
12. Klotzbucher M, Wasserfall A, Fuhrmann U (1999) Misexpression of wild-type and truncated isoforms of the high mobility group I proteins HMGI-C and HMGI(Y) in uterine leiomyomas. Am J Pathol 155: 1535-1542
13. Mantovani F, Covaceuszach S, Rustighi A, Sgarra R, Heath C, Goodwin GH, Manfioletti G (1998) NF-kappaB mediated activation is enhanced by the architectural factor HMGI-C. Nucleic Acids Res 26: 1433-1439
14. Rizzieri DA, Vredenburgh JJ, Jones R, Ross M, Shpall EJ, Hussein A, Broadwater G, Berry D, Petros WP, Gilbert C, Affronti ML, Coniglio D, Rubin P, Elkordy M, Long GD, Chao NJ, Peters WP (1999) Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support. J Clin Oncol 17: 3064-3074
15. Rogalla P, Drechsler K, Frey G, Hennig Y, Helmke B, Bonk U, Bullerdiek J (1996) HMGI-C expression patterns in human tissues -implications for the genesis of frequent mesenchymal tumors. Am J Pathol 149: 775-779
16. Rogalla P, Drechsler K, Kazmierczak B, Rippe V, Bonk U, Bullerdiek J (1997) Expression of HMGI-C, a member of the high mobility group family, in a subset of breast cancers: relationship to histologic grade. Mol Carcinogen 19: 153-156
17. Rogalla P, Drechsler K, Schröder-Babo W, Eberhardt K, Bullerdiek J (1998) HMGI-C expression patterns in non-small lung cancer and surrounding tissue. Anticancer Res 18: 3327-3330
18. Rommel B, Rogalla P, Jox A, Kalle CV, Kazmierczak B, Wolf J, Bullerdiek J (1997) HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells. Leuk Lymphoma 26: 603-607
19. Sabbatini R, Federico M, Morselli M, Depenni R, Cagossi K, Luppi M, Torelli G, Silingardi V (2000) Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy. J Clin Oncol 18: 1914-1920
20. Scala S, Portella G, Vitagliano D, Ledent C, Chiappetta G, Giancotti V, Dumont J, Fusco A (2001) HMGI-C gene expression is not required for in vivo thyroid cell transformation. Carcinogenesis 22: 251-256
21. Sezer O, Langelotz C, Blohmer JU, Schmid P, Akrivakis K, Possinger K (2000) Detection of HMGI-C in the peripheral blood of breast cancer patients. Eur J Cancer 36: 1944-1948
22. Silva JM, Dominguez G, Silva J, Garcia JM, Sanchez A, Rodriguez O, Provencio M, Espana P, Bonilla F (2001) Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res 7: 2821-2825
23. Slade MJ, Smith BM, Sinnett HD, Cross NC, Coombes RC (1999) Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J Clin Oncol 17: 870-879
24. Staats B, Bonk U, Wanschura S, Hanisch P, Schoenmakers EF, Van de Ven WJ, Bartnitzke S, Bullerdiek J (1996) A fibroadenoma with a t(4;12) (q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene family. Breast Cancer Res Treat 38: 299-303
25. Tallini G, Dal Cin P (1999) HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors. Adv Anat Pathol 6: 237-246
26. Tamimi Y, van der Poel HG, Karthaus HFM, Debruyne FM, Schalken JA (1996) A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization. Brit J Cancer 74: 573-578
27. Vallone D, Battista S, Pierantoni GM, Fedele M, Casalino L, Santoro M, Viglietto G, Fusco A, Verde P (1997) Neoplastic transformation of rat thyroid cells requires the JunB and Fra1 gene induction which is dependent on the HMGI-C products. EMBO J 17: 5310-5321
28. Zhou X, Benson KF, Ashar HR, Chada K (1995) Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376: 771-774
29. Zhou X, Chada K (1998) HMGI family proteins: architectural transcription factors in mammalian development and cancer. Keio J Med 47: 73-77